Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.

Paola Guglielmelli; Flavia Biamonte; Giada Rotunno; Valentina Artusi; Lucia Artuso; Isabella Bernardis; Elena Tenedini; Lisa Pieri; Chiara Paoli; Carmela Mannarelli; Rajmonda Fjerza; Elisa Rumi; Viktoriya Stalbovskaya; Matthew Squires; Mario Cazzola; Rossella Manfredini; Claire Harrison; Enrico Tagliafico; Alessandro M Vannucchi

doi:10.1182/blood-2013-11-536557

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.

Paola Guglielmelli
, Flavia Biamonte
, Giada Rotunno
, Valentina Artusi
, Lucia Artuso
, Isabella Bernardis
, Elena Tenedini
, Lisa Pieri
, Chiara Paoli
, Carmela Mannarelli
, Rajmonda Fjerza
, Elisa Rumi
, Viktoriya Stalbovskaya
, Matthew Squires
, Mario Cazzola
, Rossella Manfredini
, Claire Harrison
, Enrico Tagliafico
, Alessandro M Vannucchi

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

107 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	2157-2160
Fachzeitschrift	BLOOD
Jahrgang	123
Ausgabenummer	14
DOIs	https://doi.org/10.1182/blood-2013-11-536557
Publikationsstatus	Veröffentlicht - 2014

Zugriff auf Dokument

10.1182/blood-2013-11-536557

Dieses zitieren

Guglielmelli, P., Biamonte, F., Rotunno, G., Artusi, V., Artuso, L., Bernardis, I., Tenedini, E., Pieri, L., Paoli, C., Mannarelli, C., Fjerza, R., Rumi, E., Stalbovskaya, V., Squires, M., Cazzola, M., Manfredini, R., Harrison, C., Tagliafico, E., & Vannucchi, A. M. (2014). Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. BLOOD , 123(14), 2157-2160. https://doi.org/10.1182/blood-2013-11-536557

Guglielmelli, Paola ; Biamonte, Flavia ; Rotunno, Giada et al. / Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. in: BLOOD 2014 ; Jahrgang 123, Nr. 14. S. 2157-2160.

@article{a04e3939dae84c12b414ba4240709895,

title = "Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.",

keywords = "INTERNATIONAL WORKING GROUP, MYELOPROLIFERATIVE NEOPLASMS, AVAILABLE THERAPY, SURVIVAL, JAK2, EFFICACY, SAFETY",

author = "Paola Guglielmelli and Flavia Biamonte and Giada Rotunno and Valentina Artusi and Lucia Artuso and Isabella Bernardis and Elena Tenedini and Lisa Pieri and Chiara Paoli and Carmela Mannarelli and Rajmonda Fjerza and Elisa Rumi and Viktoriya Stalbovskaya and Matthew Squires and Mario Cazzola and Rossella Manfredini and Claire Harrison and Enrico Tagliafico and Vannucchi, \{Alessandro M\}",

year = "2014",

doi = "10.1182/blood-2013-11-536557",

language = "English",

volume = "123",

pages = "2157--2160",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "14",

}

Guglielmelli, P, Biamonte, F, Rotunno, G, Artusi, V, Artuso, L, Bernardis, I, Tenedini, E, Pieri, L, Paoli, C, Mannarelli, C, Fjerza, R, Rumi, E, Stalbovskaya, V, Squires, M, Cazzola, M, Manfredini, R, Harrison, C, Tagliafico, E & Vannucchi, AM 2014, 'Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.', BLOOD , Jg. 123, Nr. 14, S. 2157-2160. https://doi.org/10.1182/blood-2013-11-536557

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. / Guglielmelli, Paola; Biamonte, Flavia; Rotunno, Giada et al.
in: BLOOD , Jahrgang 123, Nr. 14, 2014, S. 2157-2160.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.

AU - Guglielmelli, Paola

AU - Biamonte, Flavia

AU - Rotunno, Giada

AU - Artusi, Valentina

AU - Artuso, Lucia

AU - Bernardis, Isabella

AU - Tenedini, Elena

AU - Pieri, Lisa

AU - Paoli, Chiara

AU - Mannarelli, Carmela

AU - Fjerza, Rajmonda

AU - Rumi, Elisa

AU - Stalbovskaya, Viktoriya

AU - Squires, Matthew

AU - Cazzola, Mario

AU - Manfredini, Rossella

AU - Harrison, Claire

AU - Tagliafico, Enrico

AU - Vannucchi, Alessandro M

PY - 2014

Y1 - 2014

KW - INTERNATIONAL WORKING GROUP

KW - MYELOPROLIFERATIVE NEOPLASMS

KW - AVAILABLE THERAPY

KW - SURVIVAL

KW - JAK2

KW - EFFICACY

KW - SAFETY

U2 - 10.1182/blood-2013-11-536557

DO - 10.1182/blood-2013-11-536557

M3 - Original Article

C2 - 24458439

SN - 0006-4971

VL - 123

SP - 2157

EP - 2160

JO - BLOOD

JF - BLOOD

IS - 14

ER -

Guglielmelli P, Biamonte F, Rotunno G, Artusi V, Artuso L, Bernardis I et al. Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. BLOOD . 2014;123(14):2157-2160. doi: 10.1182/blood-2013-11-536557